At the end of the study period, the change in peak oxygen uptake in the mavacamten group was slightly greater than in the placebo group, but the difference did not reach statistical significance.
← all excerpts
The ODYSSEY-HCM and MAPLE-HCM studies: the role of cardiac myosin inhibitors in hypertrophic cardiomyopathy (obstructive and non-obstructive).
1
—
—